Jeffrey M Conroy

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Squamous Cell Carcinoma

Prognostic Factors

Ejection Fraction

Top Venues

International journal of molecular sciences

Journal of personalized medicine

Biomarker research

This page only lists publications with an associated author ORCID identifier.

Publications

Aditya Shreenivas, Daisuke Nishizaki, Suzanna Lee, Sarabjot Pabla, Mary Nesline, Jeffrey M Conroy, Paul DePietro, Shumei Kato, Razelle Kurzrock
Clinical and Biologic Correlates of ADORA2A Transcriptomic Expression in Cancer. International journal of molecular sciences 25 (9) (2024)
Aditya Shreenivas, Daisuke Nishizaki, Suzanna Lee, Sarabjot Pabla, Mary Nesline, Jeffrey M Conroy, Paul DePietro, Shumei Kato, Razelle Kurzrock
Clinical and Biologic Correlates of ADORA2A Transcriptomic Expression in Cancer. International journal of molecular sciences 25 (9) (2024)
Aditya Shreenivas, Daisuke Nishizaki, Suzanna Lee, Sarabjot Pabla, Mary Nesline, Jeffrey M Conroy, Paul DePietro, Shumei Kato, Razelle Kurzrock
Clinical and Biologic Correlates of ADORA2A Transcriptomic Expression in Cancer. International journal of molecular sciences 25 (9) (2024)
Joel R Eisner, Gregory M Mayhew, James M Davison, Kirk D Beebe, Yoichiro Shibata, Yuelong Guo, Carol J Farhangfar, Farhang Farhangfar, Joshua M Uronis, Jeffrey M Conroy, Michael V Milburn, David Neil Hayes, Kathryn F Mileham
Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer - The Piedmont Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jessica Jou, Shumei Kato, Hirotaka Miyashita, Kartheeswaran Thangathurai, Sarabjot Pabla, Paul DePietro, Mary K Nesline, Jeffrey M Conroy, Eitan Rubin, Ramez N Eskander, Razelle Kurzrock
Cancer immunity marker RNA expression levels across gynecologic cancers: Implications for immunotherapy. Molecular cancer therapeutics (2023)
Jeffrey M Conroy, Sarabjot Pabla, Sean T Glenn, R J Seager, Erik Van Roey, Shuang Gao, Blake Burgher, Jonathan Andreas, Vincent Giamo, Melissa Mallon, Yong Hee Lee, Paul DePietro, Mary Nesline, Yirong Wang, Felicia L Lenzo, Roger D Klein, Shengle Zhang
A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors. PloS one 16 (12) (2021)
Sarbajit Mukherjee, Robert J Seager, Yong Hee Lee, Jeffrey M Conroy, Pawel Kalinski, Sarabjot Pabla
Tumor Inflammation, Obesity, and Proliferative Status as Biomarkers in Gastroesophageal Adenocarcinoma. Journal of personalized medicine 11 (12) (2021)
Sarabjot Pabla, R J Seager, Erik Van Roey, Shuang Gao, Carrie Hoefer, Mary K Nesline, Paul DePietro, Blake Burgher, Jonathan Andreas, Vincent Giamo, Yirong Wang, Felicia L Lenzo, Margot Schoenborn, Shengle Zhang, Roger Klein, Sean T Glenn, Jeffrey M Conroy
Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response. Biomarker research 9 (1) (2021)